James Barry, Executive Vice President and President of the Life Science Group at Bio-Rad Laboratories, Inc., filed a statement of changes in beneficial ownership on November 10, 2026, reporting the sale of Bio-Rad Class A Common Stock on November 9, 2026.
Key Highlights
- Reporting person: James Barry, EVP and President of the Life Science Group (LSG) at Bio-Rad Laboratories, Inc.
- Transaction: 1,400 shares of Bio-Rad A Common Stock disposed of (transaction code S) on November 9, 2026.
- Weighted average price: $385.626 per share, with individual sale prices ranging from $385.588 to $385.645, inclusive, according to the filing.
- Remaining ownership: 624.682 shares of Bio-Rad A Common Stock held directly following the reported transaction.
- Exchange and ticker: Bio-Rad Laboratories, Inc. trades on NYSE:BIO and NYSE:BIO.B, as listed in the filing.
Barry Disposes of Bio-Rad Class A Shares in November 2026 Transaction
According to the filing, James Barry, who serves as Executive Vice President and President of the Life Science Group at Bio-Rad Laboratories, Inc., sold 1,400 shares of Bio-Rad A Common Stock on November 9, 2026. The price reported for the transaction is a weighted average of $385.626 per share. The filing notes that these shares were sold across multiple transactions, with individual prices ranging from $385.588 to $385.645, inclusive. Bio-Rad Laboratories is a life science research and clinical diagnostics company headquartered in Hercules, California.
Following the reported sale, the filing indicates that Barry directly holds 624.682 shares of Bio-Rad A Common Stock. The filing was signed by James Barry on November 10, 2026. Per a footnote in the filing, Barry "undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
No derivative securities transactions were reported in this filing. The filing was submitted as an individual filing by one reporting person and was not marked as an amendment to a prior filing. Barry's address is listed as c/o Bio-Rad Laboratories, Inc., 1000 Alfred Nobel Drive, Hercules, California 94547.
What Was Disclosed
James Barry, EVP and President of the Life Science Group at Bio-Rad Laboratories, Inc. (NYSE:BIO, NYSE:BIO.B), reported selling 1,400 shares of Bio-Rad A Common Stock on November 9, 2026, at a weighted average price of $385.626, leaving him with a direct holding of 624.682 shares.



Please wait processing your request...